AMG:ETR
Amgen Inc
€416.10
arrow_upward
+0.64%(+2.65) 1D
Nov 11, 5:35:30 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMG...
Open
€412.40
High
€417.35
Low
€412.40
Mkt. cap
253.21B
Avg. vol.
556.00
Volume
324.00
52-wk high
€438.75
52-wk low
€267.60
No. of employees
32K
Open
€412.40
High
€417.35
Low
€412.40
Mkt. cap
253.21B
Avg. vol.
556.00
Volume
324.00
52-wk high
€438.75
52-wk low
€267.60
No. of employees
32K
News stories
From web sources and news partners
CoinMarketCap
·
56 minutes ago
Amgen Inc tokenized stock (xStock) Price History and Historical Data
Yahoo Finance
·
6 hours ago
Amgen (AMGN) Stock Looks Cheap Based On Future Cash Flow
Reuters
·
7 hours ago
Amgen's Sjogren's drug cuts disease activity in trial
Investor's Business Daily
·
7 hours ago
How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31.5K
Founded1980
HeadquartersThousand Oaks, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteamgen.com